A Phase 1 Trial of Imetelstat in Children with Refractory or Recurrent Solid Tumors: A Children’s Oncology Group Phase 1 Consortium Study (ADVL1112)

PURPOSE: Imetelstat is a covalently-lipidated 13-mer thiophosphoramidate oligonucleotide that acts as a potent specific inhibitor of telomerase. It binds with high affinity to the template region of the RNA component of human telomerase (hTERC ) and is a competitive inhibitor of telomerase enzymatic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Thompson, Patrick A., Drissi, Rachid, Muscal, Jodi A., Panditharatna, Eshini, Fouladi, Maryam, Ingle, Ashish M., Ahern, Charlotte H., Reid, Joel M., Lin, Tong, Weigel, Brenda J., Blaney, Susan M.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4079262/
https://ncbi.nlm.nih.gov/pubmed/24097866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-1117
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars